Healthcare Tissue Policy

HEALTHCARE TISSUE POLICY

Patient Information

Date of Birth:    Gender:    Medical Record / Patient ID:

Phone:    Email:

Relationship:    Phone:

Insurance Information

Policy Number:    Group Number:    Subscriber Name:

Medical History (Relevant to Tissue Handling)

Scope and Purpose of this Policy

This Healthcare Tissue Policy explains the institution's practices concerning the collection, handling, testing, storage, transfer, and disposition of human tissue and biological specimens removed during clinical care, including but not limited to surgical specimens, biopsies, blood, and other bodily materials. It describes intended uses (diagnostic, therapeutic, quality assurance, education, research), patient rights, conditions under which tissue may be transferred, and the patient's options regarding disposition.

Definitions

"Specimen" means any tissue or biological material removed from the patient. "De-identified" means removal of direct identifiers so that the specimen cannot reasonably be traced to the patient. "Research use" includes laboratory studies, method development, and future investigations not necessary for immediate clinical care.

Collection, Testing, and Pathology

Specimens collected during clinical procedures will be examined by pathology or other diagnostic services as medically indicated. Testing may include histology, microbiology, molecular testing, and infectious disease testing required for safe handling. Specimens may be retained for a period necessary for diagnosis, quality assurance, and in compliance with internal retention policies.

Date of Collection (if known):

Storage, Retention, and Disposal

Retention periods vary by specimen type and purpose. Where feasible, specimens retained beyond diagnostic need will be stored under secure conditions. Disposal will follow biohazard and legal requirements. Patient requests for return of removable surgical specimens are considered in accordance with institutional policy and applicable law; certain specimens required for diagnosis or public health reasons may not be released.

Transfer, Research Use, and Commercial Development

Specimens or derivatives may be transferred to other institutions, laboratories, or collaborators for diagnostic confirmation, consultation, quality assurance, or research. Where research use is authorized, specimens may be coded or de-identified; if identifiable information is retained or shared, such transfer will be limited to authorized recipients and subject to privacy safeguards. Commercial development using specimens or data derived therefrom may occur; patients will not be entitled to financial compensation for research or commercial products developed from specimens unless otherwise required by separate agreement.

Patient Choices and Authorizations

Please indicate your choices below. Where more than one option is selected, the most restrictive applicable choice will be honored unless clinical care requires otherwise.

I authorize the use of my tissue for diagnostic and clinical pathology purposes necessary for my medical care.
I authorize de-identified use of residual tissue for research and educational purposes.
I authorize identifiable use of tissue for research when additional safeguards and approvals are in place.
I authorize long-term storage of my tissue for potential future research as described above.
I authorize genetic or genomic testing of the specimen, including analysis that may yield information about hereditary conditions.
I authorize transfer of specimens to external laboratories or collaborators for the purposes indicated above.
I do NOT authorize any research use of my tissue or long-term storage beyond clinical need; dispose when clinically permissible.

Privacy, Identifiability, and Notification

Protected health information associated with specimens will be handled in accordance with the institution's privacy policies. When specimens are de-identified, direct identifiers are removed. If research or transfer involves identifiable information and law or policy requires notification or consent beyond this form, the institution will obtain further authorization prior to transfer.

Risks, Benefits, and No Financial Compensation

There is no direct clinical benefit from authorizing research or storage of specimens, although such uses may contribute to general medical knowledge. Risks include potential loss of privacy despite de-identification safeguards. By signing below, the patient acknowledges that no financial payment will be provided for the use of tissue in research or commercial development unless a separate written agreement is executed.

Revocation and Duration

This authorization is voluntary and may be revoked in writing at any time, except to the extent that actions have already been taken in reliance on the authorization. To revoke this authorization, submit a written request to the institution's health records or research oversight office. Revocation does not affect uses or disclosures made prior to receipt of the revocation. Authorization expiration date (if any):

Ownership, Custody, and Contact

The institution will maintain custody of specimens retained for clinical or authorized research use. Questions about this policy or requests regarding specimens should be directed to the designated institutional contact below.

Contact Phone:    Contact Email or Department:

Acknowledgment and Certification

By signing below, I acknowledge that I have read and understand this Healthcare Tissue Policy. I have had an opportunity to ask questions and have received satisfactory answers. I authorize the uses and disclosures checked above. I understand that clinical care will not be affected by my decisions regarding research or storage of residual tissue unless I withhold necessary diagnostic procedures.

Sign Now